A Comparison of CPAP With and Without Humidification: A Pilot Study

NCT ID: NCT02423681

Last Updated: 2017-02-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-06-30

Study Completion Date

2016-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To compare a group of patients with our standard treatment of continuous positive airway pressure (CPAP) and another group of patients with CPAP and a humidifier attached. The therapy cost and the successfulness of the treatment will be measured. A humidifier is a water chamber that is currently added to CPAP only if the patients needs it.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obstructive Sleep Apnea

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Heated humidification as first intention (HH1st)

Subjects receive heated humidification as first intention with ThermoSmart

Group Type ACTIVE_COMPARATOR

ThermoSmart

Intervention Type DEVICE

Heated humidification as first intention (HH1st) with ThermoSmart

Non-heated humidification

Subjects will receive no humidification. However they can be switched to the humidification group if patients complains of nasal dryness, congestion, nose bleed or if they had significant leak that cannot be resolved by two changes of mask.

Group Type PLACEBO_COMPARATOR

Without ThermoSmart

Intervention Type DEVICE

ThermoSmart is switched off

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ThermoSmart

Heated humidification as first intention (HH1st) with ThermoSmart

Intervention Type DEVICE

Without ThermoSmart

ThermoSmart is switched off

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Older than 18 years of age
* Diagnosed with OSA (obstructive sleep apnea) and eligible for CPAP treatment under local requirements (NICE guidelines: AHI (apnea hypopnea index) ≥ 15, or AHI \> 5 with significant daytime sleepiness)
* Naïve to CPAP therapy, i.e. have not been prescribed, or used CPAP in the last 5 years.
* Fluent in spoken and written English

Exclusion Criteria

* Significant uncontrolled cardiac disease, as per the principal investigator's discretion
* Co-existing lung disease, as per the principal investigator's discretion
* Co-existing sleep disorder, such a predominant central sleep apnoea
* Pregnancy
* Participants that are unable or unwilling to give informed consent.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fisher and Paykel Healthcare

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sara Parsons, Chief Clinical Physiologist

Role: PRINCIPAL_INVESTIGATOR

Lung Function and Sleep Unit, St George's Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Lung Function and Sleep Unit, St George's Hospital

London, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CIA-101

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.